CSRxP
@RxPricing
CSRxP fosters a national dialogue focused on the pricing of new high-cost drug therapies and striking a balance between innovation and affordability.
Joined June 2014
976 Following 3.4K Followers
Multiple studies have found Big Pharma’s price hikes have little to no connection to the cost of their development or improvements in drugs’ efficacy.
Get the facts on how the pharmaceutical industry continues to debunk its own rhetoric on innovation:
Show more
